Role of circulating tumour cells in predicting recurrence after excision of primary colorectal carcinoma

British Journal of Surgery

Volumn 94, Issue 1, 2007, Pages 96-105

  Allen Mersh, T G ^a   McCullough, T K ^a   Patel, H ^a   Wharton, R Q ^a   Glover, C ^a   Jonas, S K ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 20; MESSENGER RNA;

ACCURACY; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CIRCULATION; CLINICAL ASSESSMENT; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RECEIVER OPERATING CHARACTERISTIC; REGRESSION ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TUMOR CELL;

AGED; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KERATIN-20; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM CIRCULATING CELLS; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, MESSENGER;

EID: 33846444679     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.5526     Document Type: Article

References (31)

1. National Institute for Clinical Excellence. Improving Outcomes in Colorectal Cancers: Manual Update. Department of Health: London, 2004.
2. Allum WH, Slaney G, McConkey CC, Powell J. Cancer of the colon and rectum in the West Midlands, 1957-1981. Br J Surg 1994; 81: 1060-1063.
3. Figueredo A, Charette ML, Maroun J, Brouwers MC, Zuraw L. Adjuvant therapy for stage II colon cancer: a systematic review from the Cancer Care Ontario Program in evidence-based care's gastrointestinal cancer disease site group. J Clin Oncol 2004; 22: 3395-3407.
4. Centre for Reviews and Dissemination, University of York. The management of colorectal cancers. Effective Health Care 2004; 8: 1-12.
5. International Multicentre Pooled Analysis of Colon Cancer Trials (LMPACT) investigators. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. Lancet 1995; 345: 939-944.
6. Glaves D. Correlation between circulating cancer cells and incidence of metastases. Br J Cancer 1983; 48: 665-673.
7. Wong CW, Lee A, Shientag L, Yu J, Dong Y, Kao G et al. Apoptosis: an early event in metastatic inefficiency. Cancer Res 2001; 61: 333-338.
8. Engell HC. Cancer cells in the circulating blood: a clinical study on the occurrence of cancer cells in the peripheral blood and in venous blood draining the tumour area at operation. Acta Chir Scand Suppl 1955; 201: 1-70.
9. Burchill SA, Bradbury MF, Pittman K, Southgate J, Smith B, Selby P. Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction. Br J Cancer 1995; 71: 278-281.
10. Jonas S, Windeatt S, O-Boateng A, Fordy C, Allen-Mersh TG. Identification of carcinoembryonic antigen-producing cells circulating in the blood of patients with colorectal carcinoma by reverse transcriptase polymerase chain reaction. Gut 1996; 39: 717-721.
11. Tsavellas G, Patel H, Allen-Mersh TG. Detection and clinical significance of occult tumour cells in colorectal cancer. Eur J Surg 2001; 88: 1307-1320.
12. Wharton RQ, Jonas SK, Glover C, Khan ZA, Klokouzas A, Quinn H et al. Increased detection of circulating tumor cells in the blood of colorectal carcinoma patients using two reverse transcription-PCR assays and multiple blood samples. Clin Cancer Res 1999; 5: 4158-4163.
13. Patel H, Le Marer N, Wharton RQ, Khan ZA, Araia R, Glover C et al. Clearance of circulating tumor cells after excision of primary colorectal cancer. Ann Surg 2002; 235: 226-231.
14. Wharton RQ, Patel H, Jonas SK, Glover C, Weston M, Allen-Mersh TG. Venesection needle coring increases positive results with RT-PCR for detection of circulating cells expressing CEA mRNA. Clin Exp Metastasis 2000; 18: 291-294.
15. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal Biochem 1987; 162: 156-159.
16. Wyld DK, Selby P, Perren TJ, Jonas SK, Allen-Mersh TG, Wheeldon J et al. Detection of colorectal cancer cells in peripheral blood by reverse-transcriptase polymerase chain reaction for cytokeratin 20. Int J Cancer 1998; 79: 288-293.
17. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operator characteristic (ROC) curve. Radiology 1982; 143: 29-36.
18. Khan ZA, Jonas SK, Le-Marer N, Patel H, Wharton RQ, Tarragona A et al. P53 mutations in primary and metastatic tumors and circulating tumor cells from colorectal carcinoma patients. Clin Cancer Res 2000; 6: 3499-3504.
19. Solakoglu O, Maierhofer C, Lahr G, Breit E, Scheunemann P, Heumos I et al. Heterogeneous proliferative potential of occult metastatic cells in bone marrow of patients with solid epithelial tumors. Proc Natl Acad Sci USA 2002; 99: 2246-2251.
20. El-Hefnawy T, Raja S, Kelly L, Bigbee WL, Kirkwood JM, Luketich JD et al. Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics. Clin Chem 2004; 50: 564-573.
21. Klein CA, Blankenstein TJ, Schmidt-Kittler O, Petronio M, Polzer B, Stoecklein NH et al. Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer. Lancet 2002; 360: 683-689.
22. Schittek B, Bodingbauer Y, Ellwanger U, Blaheta HJ, Garbe C. Amplification of MelanA messenger RNA in addition to tyrosinase increases sensitivity of melanoma cell detection in peripheral blood and is associated with the clinical stage and prognosis of malignant melanoma. Br J Dermatol 1999; 141: 30-36.
23. Jung R, Petersen K, Kruger W, Wolf M, Wagener C, Zander A et al. Detection of micrometastasis by cytokeratin 20 RT-PCR is limited due to stable background transcription in granulocytes. Br J Cancer 1999; 81: 870-873.
24. Hampton R, Walker M, Marshall J, Juhl H. Differential expression of carcinoembryonic antigen (CEA) splice variants in whole blood of colon cancer patients and healthy volunteers: implication for the detection of circulating colon cancer cells. Oncogene 2002; 21: 7817-7823.
25. Gill S, Loprinzi CL, Sargent DJ, Thome SD, Alberts SR, Haller DG et al. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J Clin Oncol 2004; 22: 1797-1806.
26. Le Voyer TE, Sigurdson ER, Hanlon AL, Mayer RJ, Macdonald JS, Catalano PJ et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol 2003; 21: 2912-2919.
27. Wang Y, Jatkoe T, Zhang Y, Mutch MG, Talantov D, Jiang J et al. Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer. J Clin Oncol 2004; 22: 1564-1571.
28. Rainen L, Oelmueller U, Jurgensen S, Wyrich R, Ballas C, Schram J et al. Stabilization of mRNA expression in whole blood samples. Clin Chem 2002; 48: 1883-1890.
29. Martell M, Gomez J, Esteban JI, Sauleda S, Quer J, Cabot B et al. High-throughput real-time reverse transcription-PCR quantitation of hepatitis C virus RNA. J Clin Microbiol 1999; 37: 327-332.
30. Nakao M, Janssen JW, Flohr T, Bartram CR. Rapid and reliable quantification of minimal residual disease in acute lymphoblastic leukemia using rearranged immunoglobulin and T-cell receptor loci by LightCycler technology. Cancer Res 2000; 60: 3281-3289.
31. Compton CC, Fielding LP, Burgart LJ, Conley B, Cooper HS, Hamilton SR et al. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000; 124: 979-994.